<SEC-DOCUMENT>0001104659-23-069917.txt : 20230609
<SEC-HEADER>0001104659-23-069917.hdr.sgml : 20230609
<ACCEPTANCE-DATETIME>20230609161705
ACCESSION NUMBER:		0001104659-23-069917
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230606
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230609
DATE AS OF CHANGE:		20230609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carisma Therapeutics Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36296
		FILM NUMBER:		231005512

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		2674916422

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sesen Bio, Inc.
		DATE OF NAME CHANGE:	20180516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2318211d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:CARM="http://carismatx.com/20230606">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_CARM_carismatx.com_20230606 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230606_20230606 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001485003 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityCentralIndexKey">0001485003</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="carm-20230606.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-06to2023-06-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001485003</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-06</xbrli:startDate>
        <xbrli:endDate>2023-06-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt"></p>

<p style="margin: 0pt">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_907_edei--DocumentType_c20230606__20230606_zNSyLZFBLCue"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_900_edei--DocumentPeriodEndDate_c20230606__20230606_zLpjGuMmcuH3"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 6, 2023</ix:nonNumeric></span></b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityRegistrantName_c20230606__20230606_zQHyCTx3L2u5"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityRegistrantName">Carisma Therapeutics Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified in its
Charter)</b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20230606__20230606_z1dGXR7OzvW"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt; width: 2%">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityFileNumber_c20230606__20230606_z2aPocrDbpu3"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityFileNumber">001-36296</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt; width: 2%">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20230606__20230606_zTFd4Mp87a18"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityTaxIdentificationNumber">26-2025616</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top"><b>(State or other jurisdiction<br /> of incorporation)</b></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="text-align: center; vertical-align: top"><b>(Commission<br /> File Number)</b></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="text-align: center; vertical-align: top"><b>(IRS Employer<br /> Identification No.)</b></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="text-align: center; vertical-align: top">&#160;</td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20230606__20230606_zkEOqmCZw5dk"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityAddressAddressLine1">3675 Market Street</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20230606__20230606_zYHgHGQZVOf2"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityAddressAddressLine2">Suite&#160;200</ix:nonNumeric></span><br /> <span id="xdx_902_edei--EntityAddressCityOrTown_c20230606__20230606_zCUzr5VDT3r"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20230606__20230606_z12AVpOhDCj1"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric> </span></b></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressPostalZipCode_c20230606__20230606_z2yDEe79cjra"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:EntityAddressPostalZipCode">19104</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address of Principal Executive Offices)</b></span></td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>( Zip Code)</b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code: (<span id="xdx_90A_edei--CityAreaCode_c20230606__20230606_zaiYBe2rPXMl"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:CityAreaCode">267</ix:nonNumeric></span>) <span id="xdx_901_edei--LocalPhoneNumber_c20230606__20230606_zcuOzqyHvJGj"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:LocalPhoneNumber">491-6422</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed
Since Last Report)</b></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction
A.2 below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90B_edei--WrittenCommunications_c20230606__20230606_zrc74z5AbEDl"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 93%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20230606__20230606_z0Tbiy7UUJHd"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20230606__20230606_zUOB6JVX83hg"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230606__20230606_zA0y8U3huJMd"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="width: 45%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 24%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="width: 29%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading<br /> Symbol(s)</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><b>Name of exchange<br /> on which registered</b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--Security12bTitle_c20230606__20230606_z7NBmUngwzJg"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20230606__20230606_zbT3gsJOQj7g"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" name="dei:TradingSymbol">CARM</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--SecurityExchangeName_c20230606__20230606_zppN7pQg13ci"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20230606__20230606_zPl2ykalHfVd"><ix:nonNumeric contextRef="From2023-06-06to2023-06-06" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-size: 10pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;</span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>Item&#160;5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">At the annual meeting of stockholders of Carisma Therapeutics Inc.
(the &#8220;Company&#8221;) held on June&#160;6, 2023 (the &#8220;2023 Annual Meeting&#8221;), the Company&#8217;s stockholders approved
the amendment and restatement to the Company&#8217;s Amended and Restated 2014 Stock Incentive Plan (the &#8220;2014 Plan&#8221;), which
amendment and restatement had previously been adopted by the Company&#8217;s Board of Directors subject to stockholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
description of the amendment and restatement of the 2014 Plan, contained on pages&#160;16 to 28 of the Company&#8217;s <span style="color: blue"><a href="https://www.sec.gov/Archives/edgar/data/1485003/000110465923052069/tm2312680-2_def14a.htm#tPN4A" style="-sec-extract: exhibit">Proxy Statement for the 2023 Annual Meeting, filed with the Securities and Exchange Commission on April&#160;28, 2023</a></span></span>, is incorporated
herein by reference. A complete copy of the amendment and restatement of the 2014 Plan is attached hereto as Exhibit&#160;99.1 and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2023 Annual Meeting, the Company&#8217;s stockholders approved an amendment to the Company&#8217;s Restated Certificate of Incorporation
to increase the number of authorized shares of the Company&#8217;s common stock, $0.001 par value per share, from 100,000,000 to 350,000,000
(the &#8220;Certificate of Amendment&#8221;). The additional common stock authorized by the Certificate of Amendment has rights identical
to the Company&#8217;s currently outstanding common stock. The Company filed the Certificate of Amendment, which was effective upon filing,
with the Secretary of State of the State of Delaware on June&#160;</span>6, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The summary of the Certificate of Amendment does not purport to be
complete and is qualified in its entirety by the full text of the Certificate of Amendment, a copy of which is attached hereto as Exhibit&#160;3.1
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item&#160;5.07. Submission of Matters to a Vote of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2023 Annual Meeting, the Company&#8217;s stockholders voted
on the following proposals:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. The following nominees were elected to the Company&#8217;s Board
of Directors (the &#8220;Board&#8221;) as Class&#160;III directors for terms expiring at the 2026 annual meeting of stockholders and until
their respective successors have been duly elected and qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-size: 10pt; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Votes For</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Votes Withheld</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Broker Non-Votes</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Regina Hodits, Ph.D.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">25,650,857</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2,571,186</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2,815,899</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Bj&#246;rn Odlander, M.D., Ph.D</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,821,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">400,467</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,815,899</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. A non-binding, advisory proposal on the compensation of the Company&#8217;s
named executive officers was approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes For:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">27,924,030</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Against:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">264,478</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Abstaining:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,535</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Broker Non-Votes:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,815,899</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">3. An amendment to the Company&#8217;s Restated Certificate of Incorporation
to increase the number of authorized shares of common stock from 100,000,000 to 350,000,000 was approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes For:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">29,380,660</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Against:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,591,560</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Abstaining:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65,722</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Broker Non-Votes:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. An amendment and restatement of the Company&#8217;s Amended and
Restated 2014 Stock Incentive Plan was approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes For:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">27,113,070</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Against:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,074,066</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Abstaining:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">34,907</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Broker Non-Votes:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,815,899</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">5. The appointment of KPMG LLP as the Company&#8217;s independent registered
public accounting firm for the fiscal year ending December&#160;31, 2023 was ratified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 87%; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes For:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">30,887,544</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Against:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">63,433</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Votes Abstaining:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">86,965</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Broker Non-Votes:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6. <b>Item&#160;9.01. Financial Statements Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160; Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;<br />
Number</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 83%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2318211d1_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2318211d1_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of the Restated Certificate of Incorporation of Carisma Therapeutics Inc.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><a href="tm2318211d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2318211d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment and Restatement of Carisma Therapeutics Inc.&#8217;s Amended and Restated 2014 Stock Incentive Plan</span></a></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CARISMA THERAPEUTICS INC.</b></span></td></tr>
  <tr>
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom">/s/ Steven Kelly</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: </span>June&#160;9, 2023</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Kelly</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwjAQRE/QOyz5Fk0qUuifFhWxihQRf4NdJdhmyyateiRvaWwRl4VlmXkzQozEmlamQobzosjhiHVTaY9Q4BUZ7QWDI9tsUwi3wJtxnrX1/fsDMwoMBmY2VokOQm/tjMMyBTmdyGQST0GqVCUw34noq2dkr6ZE642uQNsSDkwNG/SaX0PCUT/JUv3qq07IzpBNQY3lIL8hliqGPXX6QXx3kOeZiEb9RGLN1DbfmtZ5qmFZYR263ID+N/oAEX1JPQ== -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2318211d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CERTIFICATE OF AMENDMENT
TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>RESTATED CERTIFICATE
OF INCORPORATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CARISMA THERAPEUTICS
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Pursuant to Section 242
of the<BR>
General Corporation Law of the State of Delaware)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Carisma Therapeutics Inc.
(the &ldquo;Corporation&rdquo;), a corporation organized and existing under and by virtue of the provisions of the General Corporation
Law of the State of Delaware (the &ldquo;General Corporation Law&rdquo;), does hereby certify as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">A. The Board of Directors
of the Corporation duly adopted resolutions, pursuant to Section 242 of the General Corporation Law, setting forth a proposed amendment
to the Restated Certificate of Incorporation of the Corporation and declaring such amendment to be advisable. The stockholders of the
Corporation duly approved such proposed amendment in accordance with Section 242 of the General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">B. The first paragraph
of Article FOURTH of the Restated Certificate of Incorporation of the Corporation be and hereby is deleted in its entirety and the following
is inserted in lieu thereof:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white">&ldquo;FOURTH: The total number of shares
of all classes of stock which the Corporation shall have authority to issue is 355,000,000 shares, consisting of (i) 350,000,000 shares
of Common Stock, $0.001 par value per share (&ldquo;Common Stock&rdquo;), and (ii) 5,000,000 shares of Preferred Stock, $0.001 par value
per share (&ldquo;Preferred Stock&rdquo;).&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in; background-color: white">IN WITNESS WHEREOF, this
Restated Certificate of Incorporation has been executed by a duly authorized officer of the Corporation on this 6th day of June, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">CARISMA THERAPEUTICS INC.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/ Steven Kelly</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Steven Kelly</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">President and Chief Executive Officer</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2318211d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CARISMA THERAPEUTICS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED 2014 STOCK INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify"><U>Purpose</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this Amended
and Restated 2014 Stock Incentive Plan (the &ldquo;<B><I>Plan</I></B>&rdquo;) of Carisma Therapeutics Inc. (formerly known as Sesen Bio,&nbsp;Inc.),
a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), is to advance the interests of the Company&rsquo;s stockholders by enhancing
the Company&rsquo;s ability to attract, retain and motivate persons who are expected to make important contributions to the Company and
by providing such persons with equity ownership opportunities and performance-based incentives that are intended to better align the interests
of such persons with those of the Company&rsquo;s stockholders. The Plan amends and restates the Amended and Restated 2014 Stock Incentive
Plan that was adopted by the board of directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;) on January 17, 2023, approved by
the Company&rsquo;s stockholders on March&nbsp;2, 2023, became effective on March 7, 2023 (the &ldquo;<B><I>Effective Date</I></B>&rdquo;)
and was amended and restated by the Board on March 7, 2023 to reflect the Company&rsquo;s name change and the reverse stock split approved
by the Company&rsquo;s stockholders on March 2, 2023. Except where the context otherwise requires, the term &ldquo;<B><I>Company</I></B>&rdquo;
shall include any of the Company&rsquo;s present or future parent or subsidiary corporations as defined in Sections 424(e)&nbsp;or (f)&nbsp;of
the Internal Revenue Code of 1986, as amended, and any regulations thereunder (the &ldquo;<B><I>Code</I></B>&rdquo;) and any other business
venture (including, without limitation, joint venture or limited liability company) in which the Company has a controlling interest, as
determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify"><U>Eligibility </U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Company&rsquo;s
employees, officers and directors, as well as consultants and advisors to the Company (as such terms consultants and advisors are defined
and interpreted for purposes of Form&nbsp;S-8 under the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;)
(or any successor form)) are eligible to be granted Awards under the Plan. Each person who is granted an Award under the Plan is deemed
a &ldquo;<B><I>Participant</I></B><I>.</I>&rdquo; &ldquo;<B><I>Award</I></B>&rdquo; means Options (as defined in Section&nbsp;5), SARs
(as defined in Section&nbsp;6), Restricted Stock (as defined in Section&nbsp;7), Restricted Stock Units (as defined in Section&nbsp;7)
and Other Stock-Based Awards (as defined in Section&nbsp;8).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><U>Administration and Delegation</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Administration
by Board of Directors</U>. The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend
and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable. The Board may construe
and interpret the terms of the Plan and any Award agreements entered into under the Plan. The Board may correct any defect, supply any
omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient and it shall
be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board&rsquo;s sole discretion and shall
be final and binding on all persons having or claiming any interest in the Plan or in any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Appointment
of Committees</U>. To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or
more committees or subcommittees of the Board (each, a &ldquo;<B><I>Committee</I></B>&rdquo;). All references in the Plan to the &ldquo;<B><I>Board</I></B>&rdquo;
shall mean the Board or a Committee of the Board or the Delegated Persons referred to in Section&nbsp;3(c)&nbsp;to the extent that the
Board&rsquo;s powers or authority under the Plan have been delegated to such Committee or such Delegated Persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delegation
to Delegated Persons</U>. Subject to any requirements of applicable law (including as applicable Sections 152(b)&nbsp;and 157(c)&nbsp;of
the General Corporation Law of the State of Delaware), the Board may, by resolution, delegate to one or more persons (including officers
of the Company) or bodies (such persons or bodies, the &ldquo;<B><I>Delegated Persons</I></B>&rdquo;) the power to grant Awards (subject
to any limitations under the Plan) to eligible service providers of the Company and to exercise such other powers under the Plan as the
Board may determine, provided that the Board shall fix: (i)&nbsp;the maximum number of Awards, and the maximum number of shares issuable
upon exercise thereof, that may be issued by such Delegated Persons, (ii)&nbsp;the time period during which such Awards, and during which
the shares issuable upon exercise thereof, may be issued, and (iii)&nbsp;the minimum amount of consideration (if any) for which such
Awards may be issued, and a minimum amount of consideration for the shares issuable upon exercise thereof; and provided further, that
no Delegated Person shall be authorized to grant Awards to itself; and provided further, that no Delegated Person shall be authorized
to grant Awards to any &ldquo;executive officer&rdquo; of the Company (as defined by Rule&nbsp;3b-7 under the Securities Exchange Act
of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;)) or to any &ldquo;officer&rdquo; of the Company (as defined by Rule&nbsp;16a-1(f)&nbsp;under
the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify"><U>Stock Available for Awards</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Number
of Shares; Share Counting</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Number of Shares</U>. Subject to adjustment under Section&nbsp;9, Awards may be made under the Plan for up to such number of shares of
common stock, $0.001 par value per share, of the Company (the &ldquo;<B><I>Common Stock</I></B>&rdquo;) as is equal to the sum of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;6,852,232
shares of Common Stock; plus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;such
additional number of shares of Common Stock as is equal to the sum of (x)&nbsp;the number of shares of Common Stock reserved for issuance
under the Company&rsquo;s 2009 Stock Incentive Plan (the &ldquo;<B><I>Prior Plan</I></B>&rdquo;) that remained available for grant under
the Prior Plan immediately prior to the closing of the Company&rsquo;s initial public offering and (y)&nbsp;the number of shares of Common
Stock (I)&nbsp;that were subject to awards granted under the Prior Plan and (II)&nbsp;that are subject to stock options assumed by the
Company pursuant to the Agreement and Plan of Merger and Reorganization between the Company (f/k/a Sesen Bio, Inc.), Seahawk Merger Sub
Inc. and CARISMA Therapeutics Inc. (the awards described in the foregoing clauses (I)&nbsp;and (II)&nbsp;together, the &ldquo;<B><I>Outstanding
Awards</I></B>&rdquo;) in each case which Outstanding Awards expire, terminate or are otherwise surrendered, canceled, forfeited or repurchased
by the Company at their original issuance price pursuant to a contractual repurchase right (subject, however, in the case of Incentive
Stock Options to any limitations of the Code); plus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;an
annual increase, to be added on the first day of each fiscal year during the term of the Plan, beginning with the fiscal year ending on
December 31, 2024, equal to the lesser of (i) 4% of the number of shares of Common Stock outstanding on the first day of such fiscal year
and (ii) the number of shares of Common Stock determined by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to adjustment under Section&nbsp;9, up
to 20,556,696 of the shares of Common Stock available for issuance under the Plan may be issued as Incentive Stock Options (as defined
in Section&nbsp;5(b)) under the Plan. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or
treasury shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Share
Counting</U>. For purposes of counting the number of shares available for the grant of Awards under the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
shares of Common Stock covered by SARs shall be counted against the number of shares available for the grant of Awards under the Plan;&nbsp;<I>provided</I>,&nbsp;<I>however</I>,
that (i)&nbsp;SARs that may be settled only in cash shall not be so counted and (ii)&nbsp;if the Company grants an SAR in tandem with
an Option for the same number of shares of Common Stock and provides that only one such Award may be exercised (a &ldquo;<B><I>Tandem
SAR</I></B>&rdquo;), only the shares covered by the Option, and not the shares covered by the Tandem SAR, shall be so counted, and the
expiration of one in connection with the other&rsquo;s exercise will not restore shares to the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
any Award (i)&nbsp;expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in
part (including as the result of shares of Common Stock subject to such Award being repurchased by the Company at the original issuance
price pursuant to a contractual repurchase right) or (ii)&nbsp;results in any Common Stock not being issued (including as a result of
an SAR that was settleable either in cash or in stock actually being settled in cash), the unused Common Stock covered by such Award shall
again be available for the grant of Awards;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that (1)&nbsp;in the case of Incentive Stock Options,
the foregoing shall be subject to any limitations under the Code, (2)&nbsp;in the case of the exercise of an SAR, the number of shares
counted against the shares available under the Plan shall be the full number of shares subject to the SAR multiplied by the percentage
of the SAR actually exercised, regardless of the number of shares actually used to settle such SAR upon exercise and (3)&nbsp;the shares
covered by a Tandem SAR shall not again become available for grant upon the expiration or termination of such Tandem SAR; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;shares
of Common Stock delivered (either by actual delivery, attestation, or net exercise) to the Company by a Participant to (i)&nbsp;purchase
shares of Common Stock upon the exercise of an Award or (ii)&nbsp;satisfy tax withholding obligations (including shares retained from
the Award creating the tax obligation) shall be added back to the number of shares available for the future grant of Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Substitute
Awards</U>. In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or
stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity
or an affiliate thereof. Substitute Awards may be granted on such terms as the Board deems appropriate in the circumstances, notwithstanding
any limitations on Awards contained in the Plan. Substitute Awards shall not count against the overall share limit set forth in Section&nbsp;4(a),
except as may be required by reason of Section&nbsp;422 and related provisions of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify"><U>Stock Options</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Board may grant options to purchase Common Stock (each, an &ldquo;<B><I>Option</I></B>&rdquo;) and determine the number of shares
of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise
of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Incentive
Stock Options</U>. An Option that the Board intends to be an &ldquo;incentive stock option&rdquo; as defined in Section&nbsp;422 of the
Code (an &ldquo;<B><I>Incentive Stock Option</I></B>&rdquo;) shall only be granted to employees of the Company (formerly known as Sesen
Bio,&nbsp;Inc.), any of the Company&rsquo;s present or future parent or subsidiary corporations as defined in Sections 424(e)&nbsp;or
(f)&nbsp;of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and
shall be subject to and shall be construed consistently with the requirements of Section&nbsp;422 of the Code. An Option that is not intended
to be an Incentive Stock Option shall be designated a &ldquo;<B><I>Nonstatutory Stock Option.</I></B>&rdquo; The Company shall have no
liability to a Participant, or any other party, if an Option (or any part thereof) that is intended to be an Incentive Stock Option is
not an Incentive Stock Option or if the Company converts an Incentive Stock Option to a Nonstatutory Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. The Board shall establish the exercise price of each Option and specify the exercise price in the applicable Option agreement.
The exercise price shall be not less than 100% of the fair market value per share of Common Stock, as determined by (or in a manner approved
by) the Board (&ldquo;<B><I>Fair Market Value</I></B>&rdquo;), on the date the Option is granted;&nbsp;<I>provided</I>&nbsp;that if the
Board approves the grant of an Option with an exercise price to be determined on a future date, the exercise price shall be not less than
100% of the Fair Market Value on such future date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Duration
of Options</U>. Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the
applicable option agreement;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that no Option will be granted with a term in excess of 10 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Options</U>. Options may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved
by the Company, together with payment in full (in a manner specified in Section&nbsp;5(f)) of the exercise price for the number of shares
for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company as soon as practicable
following exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
Upon Exercise</U>. Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
cash or by check, payable to the order of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;except
as may otherwise be provided in the applicable Option agreement or approved by the Board, in its sole discretion, by (i)&nbsp;delivery
of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the
exercise price and any required tax withholding or (ii)&nbsp;delivery by the Participant to the Company of a copy of irrevocable and unconditional
instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any
required tax withholding;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the extent provided for in the applicable Option agreement or approved by the Board, in its sole discretion, by delivery (either by actual
delivery or attestation) of shares of Common Stock owned by the Participant valued at their Fair Market Value,&nbsp;<I>provided</I>&nbsp;(i)&nbsp;such
method of payment is then permitted under applicable law, (ii)&nbsp;such Common Stock, if acquired directly from the Company, was owned
by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii)&nbsp;such Common
Stock is not subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the extent provided for in the applicable Nonstatutory Stock Option agreement or approved by the Board in its sole discretion, by delivery
of a notice of &ldquo;net exercise&rdquo; to the Company, as a result of which the Participant would receive (i)&nbsp;the number of shares
underlying the portion of the Option being exercised, less (ii)&nbsp;such number of shares as is equal to (A)&nbsp;the aggregate exercise
price for the portion of the Option being exercised divided by (B)&nbsp;the Fair Market Value on the date of exercise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the extent permitted by applicable law and provided for in the applicable Option agreement or approved by the Board, in its sole discretion,
by payment of such other lawful consideration as the Board may determine; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(6)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by
any combination of the above permitted forms of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
on Repricing</U>. Unless such action is approved by the Company&rsquo;s stockholders, the Company may not (except as provided for under
Section&nbsp;9): (1)&nbsp;amend any outstanding Option granted under the Plan to provide an exercise price per share that is lower than
the then-current exercise price per share of such outstanding Option, (2)&nbsp;cancel any outstanding option (whether or not granted under
the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&nbsp;4(b)) covering
the same or a different number of shares of Common Stock and having an exercise price per share lower than the then-current exercise price
per share of the cancelled option, (3)&nbsp;cancel in exchange for a cash payment any outstanding Option with an exercise price per share
above the then-current Fair Market Value, or (4)&nbsp;take any other action under the Plan that constitutes a &ldquo;repricing&rdquo;
within the meaning of the rules&nbsp;of the Nasdaq Stock Market (&ldquo;<B><I>Nasdaq</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify"><U>Stock Appreciation Rights</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Board may grant Awards consisting of stock appreciation rights (&ldquo;<B><I>SARs</I></B>&rdquo;) entitling the holder, upon exercise,
to receive an amount of Common Stock or cash or a combination thereof (such form to be determined by the Board) determined by reference
to appreciation, from and after the date of grant, in the Fair Market Value of a share of Common Stock over the measurement price established
pursuant to Section&nbsp;6(b). The date as of which such appreciation is determined shall be the exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Measurement
Price</U>. The Board shall establish the measurement price of each SAR and specify it in the applicable SAR agreement. The measurement
price shall not be less than 100% of the Fair Market Value on the date the SAR is granted;&nbsp;<I>provided</I>&nbsp;that if the Board
approves the grant of an SAR effective as of a future date, the measurement price shall be not less than 100% of the Fair Market Value
on such future date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Duration
of SARs</U>. Each SAR shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable
SAR agreement;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that no SAR will be granted with a term in excess of 10 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of SARs</U>. SARs may be exercised by delivery to the Company of a notice of exercise in a form (which may be electronic) approved by
the Company, together with any other documents required by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
on Repricing</U>. Unless such action is approved by the Company&rsquo;s stockholders, the Company may not (except as provided for under
Section&nbsp;9): (1)&nbsp;amend any outstanding SAR granted under the Plan to provide a measurement price per share that is lower than
the then-current measurement price per share of such outstanding SAR, (2)&nbsp;cancel any outstanding SAR (whether or not granted under
the Plan) and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section&nbsp;4(b)) covering
the same or a different number of shares of Common Stock and having an exercise or measurement price per share lower than the then-current
measurement price per share of the cancelled SAR, (3)&nbsp;cancel in exchange for a cash payment any outstanding SAR with a measurement
price per share above the then-current Fair Market Value, or (4)&nbsp;take any other action under the Plan that constitutes a &ldquo;repricing&rdquo;
within the meaning of the rules&nbsp;of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify"><U>Restricted Stock; Restricted Stock Units</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
The Board may grant Awards entitling recipients to acquire shares of Common Stock (&ldquo;<B><I>Restricted Stock</I></B>&rdquo;), subject
to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require
forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable
Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award. The
Board may also grant Awards entitling the recipient to receive shares of Common Stock or cash to be delivered at the time such Award vests
(&ldquo;<B><I>Restricted Stock Units</I></B>&rdquo;) (Restricted Stock and Restricted Stock Units are each referred to herein as a &ldquo;<B><I>Restricted
Stock Award</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Terms
and Conditions for All Restricted Stock Awards</U>. The Board shall determine the terms and conditions of a Restricted Stock Award, including
the conditions for vesting and repurchase (or forfeiture) and the issue price, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Provisions Relating to Restricted Stock</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Dividends</U>.
Unless otherwise provided in the applicable Award agreement, any dividends (whether paid in cash, stock or property) declared and paid
by the Company with respect to shares of Restricted Stock (&ldquo;<B><I>Accrued Dividends</I></B>&rdquo;) shall be paid to the Participant
only if and when such shares become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment
of Accrued Dividends will be made no later than the end of the calendar year in which the dividends are paid to stockholders of that class
of stock or, if later, the 15th day of the third month following the lapsing of the restrictions on transferability and the forfeitability
provisions applicable to the underlying shares of Restricted Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Certificates</U>. The Company may require that any stock certificates issued in respect of shares of Restricted Stock, as well as dividends
or distributions paid on such Restricted Stock, shall be deposited in escrow by the Participant, together with a stock power endorsed
in blank, with the Company (or its designee). At the expiration of the applicable restriction periods, the Company (or such designee)
shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to his or her
Designated Beneficiary. &ldquo;<B><I>Designated Beneficiary</I></B>&rdquo; means (i)&nbsp;the beneficiary designated, in a manner determined
by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant&rsquo;s death
or (ii)&nbsp;in the absence of an effective designation by a Participant, the Participant&rsquo;s estate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Additional
Provisions Relating to Restricted Stock Units</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Settlement</U>.
Upon the vesting of and/or lapsing of any other restrictions (i.e., settlement) with respect to each Restricted Stock Unit, the Participant
shall be entitled to receive from the Company such number of shares of Common Stock or (if so provided in the applicable Award agreement)
an amount of cash equal to the Fair Market Value of such number of shares of Common Stock as set forth in the applicable Award agreement.
The Board may, in its discretion, provide that settlement of Restricted Stock Units shall be deferred, on a mandatory basis or at the
election of the Participant in a manner that complies with Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voting
Rights</U>. A Participant shall have no voting rights with respect to any Restricted Stock Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Dividend
Equivalents</U>. The Award agreement for Restricted Stock Units may provide Participants with the right to receive an amount equal to
any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (&ldquo;<B><I>Dividend
Equivalents</I></B>&rdquo;). Dividend Equivalents may be paid currently or credited to an account for the Participants, may be settled
in cash and/or shares of Common Stock and may be subject to the same restrictions on transfer and forfeitability as the Restricted Stock
Units with respect to which paid, in each case to the extent provided in the applicable Award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify"><U>Other Stock-Based Awards </U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>General</U>.
Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on,
shares of Common Stock or other property, may be granted hereunder to Participants (&ldquo;<B><I>Other Stock-Based-Awards</I></B>&rdquo;).
Such Other Stock-Based Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or
as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common
Stock or cash, as the Board shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Terms
and Conditions</U>. Subject to the provisions of the Plan, the Board shall determine the terms and conditions of each Other Stock-Based
Award, including any purchase price applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify"><U>Adjustments for Changes in Common Stock and Certain Other Events</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Changes
in Capitalization</U>. In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares,
reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of
Common Stock other than an ordinary cash dividend, (i)&nbsp;the number and class of securities available under the Plan and the number
and class of securities available for issuance as Incentive Stock Options under the Plan, (ii)&nbsp;the share counting rules&nbsp;set
forth in Section&nbsp;4(a), (iii)&nbsp;the number and class of securities and exercise price per share of each outstanding Option, (iv)&nbsp;the
share and per-share provisions and the measurement price of each outstanding SAR, (v)&nbsp;the number of shares subject to and the repurchase
price per share subject to each outstanding Restricted Stock Award and (vi)&nbsp;the share and per-share-related provisions and the purchase
price, if any, of each outstanding Other Stock-Based Award, shall be equitably adjusted by the Company (or substituted Awards may be made,
if applicable) in the manner determined by the Board. Without limiting the generality of the foregoing, in the event the Company effects
a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to an outstanding
Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an
optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive,
on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding
the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reorganization
Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definition</U>.
A &ldquo;<B><I>Reorganization Event</I></B>&rdquo; shall mean: (a)&nbsp;any merger or consolidation of the Company with or into another
entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities
or other property or is cancelled, (b)&nbsp;any transfer or disposition of all of the Common Stock of the Company for cash, securities
or other property pursuant to a share exchange or other transaction or (c)&nbsp;any liquidation or dissolution of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consequences
of a Reorganization Event on Awards Other than Restricted Stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
connection with a Reorganization Event, the Board may take any one or more of the following actions as to all or any (or any portion of)
outstanding Awards other than Restricted Stock on such terms as the Board determines (except to the extent specifically provided otherwise
in an applicable Award agreement or another agreement between the Company and the Participant): (i)&nbsp;provide that such Awards shall
be assumed, or substantially equivalent Awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof),
(ii)&nbsp;upon written notice to a Participant, provide that all of the Participant&rsquo;s unvested and/or unexercised Awards will terminate
immediately prior to the consummation of such Reorganization Event unless exercised by the Participant (to the extent then exercisable)
within a specified period following the date of such notice, (iii)&nbsp;provide that outstanding Awards shall become exercisable, realizable,
or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv)&nbsp;in
the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment
for each share surrendered in the Reorganization Event (the &ldquo;<B><I>Acquisition Price</I></B>&rdquo;), make or provide for a cash
payment to Participants with respect to each Award held by a Participant equal to (A)&nbsp;the number of shares of Common Stock subject
to the vested portion of the Award (after giving effect to any acceleration of vesting that occurs upon or immediately prior to such Reorganization
Event) multiplied by (B)&nbsp;the excess, if any, of (I)&nbsp;the Acquisition Price over (II)&nbsp;the exercise, measurement or purchase
price of such Award and any applicable tax withholdings, in exchange for the termination of such Award, (v)&nbsp;provide that, in connection
with a liquidation or dissolution of the Company, Awards shall convert into the right to receive liquidation proceeds (if applicable,
net of the exercise, measurement or purchase price thereof and any applicable tax withholdings) and (vi)&nbsp;any combination of the foregoing.
In taking any of the actions permitted under this Section&nbsp;9(b)(2), the Board shall not be obligated by the Plan to treat all Awards,
all Awards held by a Participant, or all Awards of the same type, identically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
the terms of Section&nbsp;9(b)(2)(i), in the case of outstanding Restricted Stock Units that are subject to Section&nbsp;409A of the Code:
(i)&nbsp;if the applicable Restricted Stock Unit agreement provides that the Restricted Stock Units shall be settled upon a &ldquo;change
in control event&rdquo; within the meaning of Treasury Regulation Section&nbsp;1.409A-3(i)(5)(i), and the Reorganization Event constitutes
such a &ldquo;change in control event&rdquo;, then no assumption or substitution shall be permitted pursuant to Section&nbsp;9(b)(2)(i)(i)&nbsp;and
the Restricted Stock Units shall instead be settled in accordance with the terms of the applicable Restricted Stock Unit agreement; and
(ii)&nbsp;the Board may only undertake the actions set forth in clauses (iii), (iv)&nbsp;or (v)&nbsp;of Section&nbsp;9(b)(2)(i)&nbsp;if
the Reorganization Event constitutes a &ldquo;change in control event&rdquo; as defined under Treasury Regulation Section&nbsp;1.409A-3(i)(5)(i)&nbsp;and
such action is permitted or required by Section&nbsp;409A of the Code; if the Reorganization Event is not a &ldquo;change in control event&rdquo;
as so defined or such action is not permitted or required by Section&nbsp;409A of the Code, and the acquiring or succeeding corporation
does not assume or substitute the Restricted Stock Units pursuant to clause (i)&nbsp;of Section&nbsp;9(b)(2)(i), then the unvested Restricted
Stock Units shall terminate immediately prior to the consummation of the Reorganization Event without any payment in exchange therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
purposes of Section&nbsp;9(b)(2)(i)(i), an Award (other than Restricted Stock) shall be considered assumed if, following consummation
of the Reorganization Event, such Award confers the right to purchase or receive pursuant to the terms of such Award, for each share of
Common Stock subject to the Award immediately prior to the consummation of the Reorganization Event, the consideration (whether cash,
securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock
held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type
of consideration chosen by the holders of a majority of the outstanding shares of Common Stock);&nbsp;<I>provided</I>,&nbsp;<I>however</I>,
that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation
(or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration
to be received upon the exercise or settlement of the Award to consist solely of such number of shares of common stock of the acquiring
or succeeding corporation (or an affiliate thereof) that the Board determined to be equivalent in value (as of the date of such determination
or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a
result of the Reorganization Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Consequences
of a Reorganization Event on Restricted Stock</U>. Upon the occurrence of a Reorganization Event other than a liquidation or dissolution
of the Company, the repurchase and other rights of the Company with respect to outstanding Restricted Stock shall inure to the benefit
of the Company&rsquo;s successor and shall, unless the Board determines otherwise, apply to the cash, securities or other property which
the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as
they applied to such Restricted Stock;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that the Board may provide for termination or deemed
satisfaction of such repurchase or other rights under the instrument evidencing any Restricted Stock or any other agreement between a
Participant and the Company, either initially or by amendment. Upon the occurrence of a Reorganization Event involving the liquidation
or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted
Stock or any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock then outstanding
shall automatically be deemed terminated or satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify"><U>General Provisions Applicable to Awards</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transferability
of Awards</U>. Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted,
either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive
Stock Option, pursuant to a qualified domestic relations order, and, during the life of the Participant, shall be exercisable only by
the Participant;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that the Board may permit or provide in an Award for the gratuitous transfer
of the Award by the Participant to or for the benefit of any immediate family member, family trust or other entity established for the
benefit of the Participant and/or an immediate family member thereof if the Company would be eligible to use a Form&nbsp;S-8 under the
Securities Act for the registration of the sale of the Common Stock subject to such Award to such proposed transferee;&nbsp;<I>provided</I>&nbsp;<I>further</I>,
that the Company shall not be required to recognize any such permitted transfer until such time as such permitted transferee shall, as
a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming
that such transferee shall be bound by all of the terms and conditions of the Award. References to a Participant, to the extent relevant
in the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section&nbsp;10(a)&nbsp;shall
be deemed to restrict a transfer to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Documentation</U>.
Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine. Each Award may contain terms
and conditions in addition to those set forth in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Board
Discretion</U>. Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award.
The terms of each Award need not be identical, and the Board need not treat Participants uniformly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination
of Status</U>. The Board shall determine the effect on an Award of the disability, death, termination or other cessation of employment,
authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period
during which, the Participant, or the Participant&rsquo;s legal representative, conservator, guardian or Designated Beneficiary, may exercise
rights under the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Withholding</U>.
The Participant must satisfy all applicable federal, state, and local or other income and employment tax withholding obligations before
the Company will deliver stock certificates or otherwise recognize ownership of Common Stock under an Award. The Company may decide to
satisfy the withholding obligations through additional withholding on salary or wages. If the Company elects not to or cannot withhold
from other compensation, the Participant must pay the Company the full amount, if any, required for withholding or have a broker tender
to the Company cash equal to the withholding obligations. Payment of withholding obligations is due before the Company will issue any
shares on exercise, vesting or release from forfeiture of an Award or at the same time as payment of the exercise or purchase price unless
the Company determines otherwise. If provided for in an Award or approved by the Board in its sole discretion, a Participant may satisfy
such tax obligations in whole or in part by delivery (either by actual delivery or attestation) of shares of Common Stock, including shares
retained from the Award creating the tax obligation, valued at their Fair Market Value;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, except
as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed
the Company&rsquo;s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax
purposes, including payroll taxes, that are applicable to such supplemental taxable income), except that, to the extent that the Company
is able to retain shares of Common Stock having a fair market value (determined or approved by the Company) that exceeds the statutory
minimum applicable withholding tax without financial accounting implications or the Company is withholding in a jurisdiction that does
not have a statutory minimum withholding tax, the Company may retain such number of shares of Common Stock (up to the number of shares
having a fair market value equal to the maximum individual statutory rate of tax (determined or approved by, the Company)) as the Company
shall determine to be necessary to satisfy the tax liability associated with any Award. Shares used to satisfy tax withholding requirements
cannot be subject to any repurchase, forfeiture, unfulfilled vesting or other similar requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment
of Award</U>. Except as otherwise provided in Sections 5(g)&nbsp;and 6(e)&nbsp;with respect to repricings and Section&nbsp;11(d)&nbsp;with
respect to actions requiring stockholder approval, the Board may amend, modify or terminate any outstanding Award, including but not limited
to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting
an Incentive Stock Option to a Nonstatutory Stock Option. The Participant&rsquo;s consent to such action shall be required unless (i)&nbsp;the
Board determines that the action, taking into account any related action, does not materially and adversely affect the Participant&rsquo;s
rights under the Plan or (ii)&nbsp;the change is permitted under Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Conditions
on Delivery of Stock</U>. The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions
from shares previously issued or delivered under the Plan until (i)&nbsp;all conditions of the Award have been met or removed to the satisfaction
of the Company, (ii)&nbsp;in the opinion of the Company&rsquo;s counsel, all other legal matters in connection with the issuance and delivery
of such shares have been satisfied, including any applicable securities laws and regulations and any applicable stock exchange or stock
market rules&nbsp;and regulations, and (iii)&nbsp;the Participant has executed and delivered to the Company such representations or agreements
as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules&nbsp;or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acceleration</U>.
The Board may at any time provide that any Award shall become immediately exercisable in whole or in part, free of some or all restrictions
or conditions, or otherwise realizable in whole or in part, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify"><U>Miscellaneous </U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Right To Employment or Other Status</U>. No person shall have any claim or right to be granted an Award by virtue of the adoption of the
Plan, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship
with the Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant
free from any liability or claim under the Plan, except as expressly provided in the applicable Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights As Stockholder; Clawback</U>. Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall
have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming
the record holder of such shares. In accepting an Award made under the Plan on and after the Effective Date (as defined in Section&nbsp;1),
the Participant agrees to be bound by any clawback policy that the Company has in effect or may adopt in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effective
Date and Term of Plan</U>. The Amended and Restated 2014 Stock Incentive Plan became effective on the Effective Date. No Awards shall
be granted under the Plan after the expiration of 10 years from the Effective Date, but Awards previously granted may extend beyond that
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment
of Plan</U>. The Board may amend, suspend or terminate the Plan or any portion thereof at any time provided that (i)&nbsp;to the extent
required by Section&nbsp;162(m)&nbsp;of the Code, no Award granted to a Participant that is intended to comply with Section&nbsp;162(m)&nbsp;of
the Code after the date of such amendment shall become exercisable, realizable or vested, as applicable to such Award, unless and until
the Company&rsquo;s stockholders approve such amendment in the manner required by Section&nbsp;162(m)&nbsp;of the Code; and (ii)&nbsp;no
amendment that would require stockholder approval under the rules&nbsp;of the Nasdaq Stock Market may be made effective unless and until
the Company&rsquo;s stockholders approve such amendment. In addition, if at any time the approval of the Company&rsquo;s stockholders
is required as to any other modification or amendment under Section&nbsp;422 of the Code or any successor provision with respect to Incentive
Stock Options, the Board may not effect such modification or amendment without such approval. Unless otherwise specified in the amendment,
any amendment to the Plan adopted in accordance with this Section&nbsp;11(d)&nbsp;shall apply to, and be binding on the holders of, all
Awards outstanding under the Plan at the time the amendment is adopted, provided the Board determines that such amendment, taking into
account any related action, does not materially and adversely affect the rights of Participants under the Plan. No Award shall be made
that is conditioned upon stockholder approval of any amendment to the Plan unless the Award provides that (i)&nbsp;it will terminate or
be forfeited if stockholder approval of such amendment is not obtained within no more than 12 months from the date of grant and (2)&nbsp;it
may not be exercised or settled (or otherwise result in the issuance of Common Stock) prior to such stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorization
of Sub-Plans (including Grants to non-U.S. Employees)</U>. The Board may from time to time establish one or more sub-plans under the Plan
for purposes of satisfying applicable securities, tax or other laws of various jurisdictions. The Board shall establish such sub-plans
by adopting supplements to the Plan containing (i)&nbsp;such limitations on the Board&rsquo;s discretion under the Plan as the Board deems
necessary or desirable or (ii)&nbsp;such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem
necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only
to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants
in any jurisdiction which is not the subject of such supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compliance
with Section&nbsp;409A of the Code</U>. Except as provided in individual Award agreements initially or by amendment, if and to the extent
(i)&nbsp;any portion of any payment, compensation or other benefit provided to a Participant pursuant to the Plan in connection with his
or her employment termination constitutes &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section&nbsp;409A of
the Code and (ii)&nbsp;the Participant is a specified employee as defined in Section&nbsp;409A(a)(2)(B)(i)&nbsp;of the Code, in each case
as determined by the Company in accordance with its procedures, by which determinations the Participant (through accepting the Award)
agrees that he or she is bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six
months plus one day after the date of &ldquo;separation from service&rdquo; (as determined under Section&nbsp;409A of the Code) (the &ldquo;<B><I>New
Payment Date</I></B>&rdquo;), except as Section&nbsp;409A of the Code may then permit. The aggregate of any payments that otherwise would
have been paid to the Participant during the period between the date of separation from service and the New Payment Date shall be paid
to the Participant in a lump sum on such New Payment Date, and any remaining payments will be paid on their original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company makes no representations
or warranty and shall have no liability to the Participant or any other person if any provisions of or payments, compensation or other
benefits under the Plan are determined to constitute nonqualified deferred compensation subject to Section&nbsp;409A of the Code but do
not to satisfy the conditions of that section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitations
on Liability</U>. Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, employee, or agent of
the Company will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability,
or expense incurred in connection with the Plan, nor will such individual be personally liable with respect to the Plan because of any
contract or other instrument he or she executes in his or her capacity as a director, officer, employee, or agent of the Company. The
Company will indemnify and hold harmless each director, officer, employee, or agent of the Company to whom any duty or power relating
to the administration or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys&rsquo;
fees) or liability (including any sum paid in settlement of a claim with the Board&rsquo;s approval) arising out of any act or omission
to act concerning the Plan unless arising out of such person&rsquo;s own fraud or bad faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law</U>. The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of
the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a
jurisdiction other than the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>carm-20230606.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiPKbOdzZR+6YkxtmBxbfn6jyQkuTt6CCPzVgcm4XYJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:CARM="http://carismatx.com/20230606" elementFormDefault="qualified" targetNamespace="http://carismatx.com/20230606">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://carismatx.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="carm-20230606_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="carm-20230606_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>carm-20230606_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>carm-20230606_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://carismatx.com/role/Cover" xlink:href="carm-20230606.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://carismatx.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139790962611984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  06,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Carisma Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001485003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2025616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3675 Market Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">491-6422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CARM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm2318211d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="carm-20230606.xsd" xlink:type="simple"/>
    <context id="From2023-06-06to2023-06-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001485003</identifier>
        </entity>
        <period>
            <startDate>2023-06-06</startDate>
            <endDate>2023-06-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-06to2023-06-06">0001485003</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-06to2023-06-06">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-06-06to2023-06-06">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-06-06to2023-06-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-06to2023-06-06">2023-06-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-06to2023-06-06">Carisma Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-06to2023-06-06">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-06to2023-06-06">001-36296</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-06to2023-06-06">26-2025616</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-06to2023-06-06">3675 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-06-06to2023-06-06">Suite&#160;200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-06to2023-06-06">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-06to2023-06-06">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-06to2023-06-06">19104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-06to2023-06-06">267</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-06to2023-06-06">491-6422</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-06to2023-06-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-06to2023-06-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-06to2023-06-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-06to2023-06-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-06to2023-06-06">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-06to2023-06-06">CARM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-06to2023-06-06">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-06to2023-06-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"  B@LE6EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
M4$L#!!0    ( "*"R5:JQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&UL
MC5'1;L(P#/R5*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<
MV;K<7187XM.!Z)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[
M=)IEL]1;#&:Y&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C
M%<K<9":)-5U>B/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@
MA1REW^CUK7H\@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146
ML*:B]1!DZ)'!=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E
M5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04
M"  B@LE6)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM
M?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(H
MND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++
M3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$
M%     @ (H+)5F60>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&UL
MK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QX
MWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#
M4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$
MJ+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:
M!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U5
M9"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\
MUDX:?^:+X3]>?P%02P$"% ,4    "  B@LE6!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "*"R5;R
M:Y3)[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( "*"R5:97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ (H+)5D5TR@I^!
MO!$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( "*"R5:?H!OPL0(  .(,   -              "  <$,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ (H+)5I>*NQS     $P(   L
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64$L%!@     )  D /@(  !44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2318211d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://carismatx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2318211d1_8k.htm">tm2318211d1_8k.htm</File>
    <File>carm-20230606.xsd</File>
    <File>carm-20230606_lab.xml</File>
    <File>carm-20230606_pre.xml</File>
    <File>tm2318211d1_ex3-1.htm</File>
    <File>tm2318211d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2318211d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2318211d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "carm-20230606_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "carm-20230606_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "carm-20230606.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "CARM",
   "nsuri": "http://carismatx.com/20230606",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318211d1_8k.htm",
      "contextRef": "From2023-06-06to2023-06-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://carismatx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318211d1_8k.htm",
      "contextRef": "From2023-06-06to2023-06-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://carismatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-23-069917-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-069917-xbrl.zip
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M6/F%Z'^ -Q1'^2_$MH$L+XV&DVNJY5]02P,$%     @ (H+)5CT7:RG_"@
M;(<  !4   !C87)M+3(P,C,P-C V7VQA8BYX;6S-G5]3Z[@9QN\[T^^@36_:
MF1-"H-TI[&%W.#FPDUD6*.&<;;O3V5%L$3PH$BL[D'S[2K;EV+)>V]"I)"X@
M6,\K/[)^D>0_DC_^L%U3]$)$FG!V-IH>'(X081&/$[8Z&WU9C,\7L_E\A-(,
MLQA3SLC9B/'1#]__\0](_GS\9CQ&EPFA\2GZS*/QG#WP[] U7I-3]"-A1.",
MB^_05TPW:@N_3"@1:,;7SY1D1"84.SY%?SN8_GV)QN,!^7XE+.;BR]V\RO<Q
MRY[3T\GD]?7U@/$7_,K%4WH0\?6P#!<9SC9IE=OA]K#\*<(_TH0]G:I?2YP2
M)(\72T^W:7(V4OLM=_MZ?,#%:G)T>#B=_//GJT7T2-9XG#!UW"(RTE$J%UO<
M].3D9)*G:FE+N5T*JO=Q/-%VJIQE:M*AKSE)D],TMW?%(YSEU=Z[&P0JU']C
M+1NK3>/IT?AX>K!-XY$^^/D1%)R2._* \F*>9KMGB5*:*!)&Y;9'01[L9J@0
M$Q4_862%,Q*K'9VH'4V_53OZ4[GY"B\)'2&EE'R Y3IIY%4&35R;O24BX?$%
M>Y]K,]J3??G=$=G_4(!ZO/,BW/,,TW>9KT<ZMWU-WG?$]W'NC[1LY\G[CG0M
M\O]B.VM;?O/AM1]7JC9>R4\-BV2;R0Z,Q-JDRJ*C!<[WD'<,9=Y5[CQJY$M5
M:\Y%N^RJ9\SS3$ETL.(ODY@D,N^CZ>]_51_'Q<>\Z/+?WV9<C@;.EVDF<)3I
MW/*BG(TLZ1/3EE*>"^T-BZBG@*5B$G'9/3UG8UH<RB+\0?"U=;=ER;DE\3>Z
MK.*+0R-W 1AMR 1)^49$Y$TU4W<+':72T9I*A1I6$3;^LAA]GVO0KUKUGX^3
M?2Z.*EL.A39KPK)[F:NE%,UD5U5M,Z5KNIX61$5;#)GUK"5(:3Q4\KG<>:P,
M7%*\LA3!2'=5S59;NIX;B4%4M,V16=.5!BF1SZK^3-)(),]J>-]5EH;,><5;
M3+;JOZ8)"X.V,9B&FM9C(W]'5HGJ:I0-=<Y+U,:.)@W0N^X&.FV;_8)5' 0X
M0QR"/4<]"%51'EDZ9VR#Z1UYYJ(+H:;,-3DVDR8P=4U0G%B,@7@46E2(/5+Q
MCXT\FR>"[GK!:"E=LP%8-?$P9$$18O<&0E+)_7-R+S!+$]68]8+2ECH_#0',
MMDY)#%U0K #FX%.52N^?EL4CH53=,\"LOV&QB5T3 QLVF6DK@Z(&M =RDT>@
M,B0L="Y>U*A=#IT&%KBF]PE0RW870Y4X6(Q,AP-)RL.0BO-(4^V610]'+:5K
M@@"K)CN&+"AJ[-Y 7@HYRO5A@'+!XD&85#H_D!@V[8B4H@ !:3KKPT.J?<-Q
MF:01IH6?2[DM[2BB1>L:$M"N"4I+&!0LD#L0F") <Y.'>(?F7P2+8<C4E'Z
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M..])-RW-O]!'A1<4"P%]"C(PJ2"71A77*240WTJZ,5Z=EBSBM6T,+K.,Z!1
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M[#4RW3 _=&2_?)@?2/X$4$L#!!0    ( "*"R5;EQS(U/#H  .HW 0 6
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MGE_O+#Q/;5-RA@J\(L0M-4WJ*>D8'<%>@DP!9U?&W+J7L;_M.LN>D[WT*MF
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M=*JF*6IBDQCMXS0?22'$J/E2S;7(@5VF5F^&Z<)1=0,'=<@7;&_1W%= ^1+
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M6*@M+D,K5UU1<0_(I[)'_.(48V64MEK1QHC"8HE"Q5QDHPWGX:IDXP6%Z3*
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M.:SHLJLX67PHVL;*YP*19>NL93:^)D7-0A@=5+"/+>WU)*LVH+OV,'2*:7?
MM0O&J;'X8:_A&DW/NO$SY!UHW97_1 ""'!/WEE3UZ]Q:+" MK)NL]'V%'"68
M _?O-6EKS5!N.UN$NNA4PQD3HC"KHJ+!:"P1@T*B84L\D*;+3LJFJ,,-O# &
MK&F]K&*"6*Q@0S9P:"L83#FK':#/D'7HZ]):+S4X [5\W*98+Y+(Q:[Q( 3/
M( .ZW%OO.%5O0WEEE2[(2@?YJ_P*/,:P\0O)Z*P=C7X9\ O%W) 6[U E2E\
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M.RL"'8ZQQTC]4A\9YLDX@ ]%MIJ\-NJ0TRWXACOD[6 R&5UZ>P,1ID;EA8S
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M! ._B=XFP&W^8]Q7>_,E];;ZX<L?7O\+$;@/_W[^_=MO_S]02P$"% ,4
M"  B@LE6RH4?J#\#  #X"P  $0              @ $     8V%R;2TR,#(S
M,#8P-BYX<V102P$"% ,4    "  B@LE6/1=K*?\*  !LAP  %0
M    @ %N P  8V%R;2TR,#(S,#8P-E]L86(N>&UL4$L! A0#%     @ (H+)
M5O$'YU)5!P  PU@  !4              ( !H X  &-A<FTM,C R,S V,#9?
M<')E+GAM;%!+ 0(4 Q0    ( "*"R5:U6FY'L!@  *"T   2
M  "  2@6  !T;3(S,3@R,3%D,5\X:RYH=&U02P$"% ,4    "  B@LE6$=]'
M838%   G&0  %0              @ $(+P  =&TR,S$X,C$Q9#%?97@S+3$N
M:'1M4$L! A0#%     @ (H+)5N7',C4\.@  ZC<! !8              ( !
M<30  '1M,C,Q.#(Q,60Q7V5X.3DM,2YH=&U02P4&      8 !@", 0  X6X
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
